D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CBIO holding history
Crescent Biopharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CBIO overviewAll 13F holders of CBIOFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −36,630−100.0% | Sold out | Holders |
| Q3 2022 | 36,630 | $20.0K | <0.1% | −205,393−84.9% | Reduced | Holders |
| Q2 2022 | 242,023 | $144.0K | <0.1% | −13,661−5.3% | Reduced | Holders |
| Q1 2022 | 255,684 | $291.0K | <0.1% | −12,187−4.5% | Reduced | Holders |
| Q4 2021 | 267,871 | $385.0K | <0.1% | −48,915−15.4% | Reduced | Holders |
| Q3 2021 | 316,786 | $694.0K | <0.1% | +51,315+19.3% | Added | Holders |
| Q2 2021 | 265,471 | $616.0K | <0.1% | −250,427−48.5% | Reduced | Holders |
| Q1 2021 | 515,898 | $1.55M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.